Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Feb 13, 2023 10:48am
685 Views
Post# 35282995

Hard to find, under the threaded view…strong volume & price

Hard to find, under the threaded view…strong volume & price

Monday am, Nas premarket. Usually not much of an indicator. 

Today however, some premarket trades were reasonable size. Leading to a 22k premarket volume.
Then on open, again fair volume on the NAS.
Could be trading adjustments. Went too low too fast " over sold" & the trading algorithms picking up buys?
or any speculation we can think of.
we do know there is a CAR-t presentation next month. Not published by Onc, but was on Twitter.
We do know, it has now been perhaps the longest in company history of absolute zero communications.
No paid advertising, no trial updates, no letter to shareholders.
All of which were common up to this point in time a year ago.
so, we wait.....
I feel positive going forward.
im in for the science which has all been positive....recent 3-4 months.

 

<< Previous
Bullboard Posts
Next >>